慢性閉塞性肺疾患の薬剤療法をターゲットにする現在のコンセプト:パーソナライズされた管理に向けた進展
Prescott G Woodruff1, Alvar Agusti2, Nicolas Roche3
1Division of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine and Cardiovascular Research Institute, University of California, San Francisco, CA, USA.
Lancet (London, England)
|May 7, 2015
まとめ
慢性阻害性肺疾患 (COPD) を理解するには,患者のサブグループを特定する必要があります. バイオマーカーで特定のエンドタイプをターゲットにすることで,パーソナライズされたCOPD治療と薬物開発を進めるでしょう.
科学分野:
- 肺内医学 肺内医学 肺内医学
- トランスレーションアル・リサーチ
- バイオマーカーの発見
背景:
- 慢性阻害性肺疾患 (COPD) は,世界的に健康と経済に重大な影響を及ぼす複雑で異質な呼吸器疾患である.
- 現在の治療ガイドラインでは,COPDの管理を症状の改善とリスクの軽減に分類し,個別化された医療へと移行しています.
- 臨床的フェノタイプは有用であるが,重複し,多様な生物学的メカニズムから生じる可能性があるため,より深い理解が必要である.
研究 の 目的:
- COPDにおけるエンドタイプという概念を,異なる病理生理学的サブタイプとして探求する.
- これらのエンドタイプのための特定のバイオマーカーを特定することの重要性を強調する.
- エンドタイプベースのアプローチが,COPDの臨床実務と薬物開発をどのように洗練できるかを議論する.
主な方法:
- 現在のCOPDガイドラインと治療戦略のレビュー.
- パーソナライズド医療の指針化における臨床フェノタイプの限界についての議論.
- 疾患の複雑性におけるエンドタイプやネットワーク分析などの新興概念の探求.
主要な成果:
- 臨床的フェノタイプは,COPDの生物学的異質性を完全に捉えることができないかもしれません.
- 検証されたバイオマーカーで特定のエンドタイプをターゲットにすることが,より効果的な治療法をもたらす可能性が高い.
- 特定の炎症経路を標的とする新薬は,試験の成功のためにエンドタイプとバイオマーカーの識別を必要とします.
結論:
- COPDのパーソナライズされた治療は,基礎となるエンドタイプを理解し,ターゲットにすることへの移行を必要とします.
- バイオマーカーは,エンドタイプを特定し,COPDの精密医療を可能にするために不可欠です.
- ネットワーク分析とさらなる研究は,COPDのような複雑な疾患を再分類し,新しい治療法を開発するために不可欠です.
関連する概念動画
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.4K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.4K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K